On July 30, 2018, the FDA issued a warning against the use of energy-based (most commonly radiofrequency or laser) devices utilized to perform vaginal rejuvenation procedures. These devices have been approved by the FDA for gynecological purposes such as the destruction of abnormal or pre-cancerous cervical or vaginal tissue and genital warts. However, several manufacturers of these devices have been aggressively marketing them to women for uses which are not approved by the FDA nor properly tested including:

  1. Cosmetic vaginal procedures/vaginal rejuvenation;
  2. Treatment of menopause related symptoms;

The bus accident April 9th that injured many of the 38 Huntington student passengers on board is yet further confirmation of an alarming trend-  collisions between commercial busses and low overpasses.

On April 9th, a bus carrying dozens of students, struck a low-clearance overpass on Long Island’s Southern State Parkway. Initial reports indicate that the driver, who was unfamiliar with commercial vehicle restrictions on the parkway, was relying upon a GPS device which did not provide warnings or information about low overpasses. This crash is similar to crashes in Syracuse, NY, and Boston, MA.  In each of those crashes, the driver followed a GPS and passed signs indicating a low clearance ahead. Anapol Weiss represented passengers in those bus crashes.

Most people are surprised at the number of low bridge hits that occur with Trucks and busses. One study estimates 200 hits per year in New York state alone. Many of these cases involve drivers following a GPS right into a bridge. In most cases, the driver is not specifically aware that the GPS will lead them to a low bridge. Most GPS units do not carry a warning. GPS companies have the low bridge information and sell GPS units with a vehicle height input but there is normally no warning that a particular GPS should not be used in a commercial vehicle. The problem was so severe that in 2013, USDOT did a study and issued a warning card that can be placed on a commercial vehicle visor.

By Dani Kass

Law360, New York (September 27, 2017, 3:05 PM EDT) — The Philadelphia Federation of Teachers Health and Welfare Fund has filed a potential class action in Pennsylvania state court, joining a string of parties accusing Endo International PLC of fraudulently marketing its opioid painkillers as safe and effective for chronic pain.

The health fund on Monday claimed the Opana ER and Percocet maker furthered the opioid crisis by spending millions of dollars a year advertising its painkillers for long-term use despite having no proof that such use was effective and knowing there were severe addiction risks. The complaint alleges violations of the Pennsylvania Unfair Trade Practices and Consumer Protection Law, unjust enrichment, breach of implied warranties and civil conspiracy.

By Justin Hughes

More complaints are rolling in about exhaust leaks in the Ford Explorer causing fumes to leak into the SUV’s passenger compartment and now, the National Highway Traffic Safety Administration is expanding its investigation into the leaks to include 1.33 million vehicles built between 2011 and 2017, according to Automotive News.

The number of exhaust fume complaints has risen from the previously reported number of 450 to 2,700 complaints. Three crashes and 41 injuries were also reported.

By Joel Feldman

Distracted driving has rightly been called an “epidemic.” And distracted driving statistics support claims that this epidemic is getting worse. According to the National Highway Traffic Safety Administration (NHTSA), in 2015, distracted driving-related fatalities increased in the U.S. at a faster percentage than those attributable to drunk driving, drowsy driving, speeding or failing to wear a seatbelt. Early estimates for 2016 appear to be almost as bad.

Still, virtually every time we drive, we see others flying by us and looking at their phones rather than at the road.

On May 16, 2017, the FDA concluded that the Type 2 diabetes medication Canagliflozin (Invokana, Invokamet and Invokamet XR) causes an increased risk of leg and foot amputations. The FDA will now require the most prominent black box warning to be added to the Canagliflozin drug labels. This new warning came at the conclusion of two large clinical trials, one of which showed that leg and foot amputations occurred about twice as often in patients treated with Canagliflozin versus a placebo.

The Unsafe Drug and Medical Device Team at Anapol Weiss is investigating Canagliflozin cases on behalf of patients who have suffered an amputation. In the event you receive any calls regarding these products, we welcome the opportunity to work with you and your clients.

Millions of passengers rely on buses and other forms of public transportation to get them from point A to point B on a daily basis. As passengers, we trust that the bus driver will safely get us to our destination. This is not always the case, however.

Tragic bus accidents like the May 15th accident that injured dozens of C.W. Henry School students change lives. Bus accident injuries can be severe and permanent, and they can lead to extensive medical care and lost wages. A bus company should be held accountable when it fails to live up to its promise to safely transport passengers to their destination.

Fighting against the bus company can be difficult. They have a team of lawyers dedicated to defending them. Bus crash victims deserve their own team of bus accident lawyers. Anapol Weiss has that covered.

Owners of 2009, 2010, and 2011 Mercury Marquis, Ford Crown Victoria, and Lincoln Town Car vehicles are reporting a dangerous fire hazard.

At issue is an electrical wiring problem in the both the passenger and driver side vanity mirrors that can lead to electrical components heating to such a temperature that they burn and melt the vehicle’s sun visor and the material surrounding it.

In fact, one driver reports that they suffered second to third degree burns due to the melting components falling from above while driving after the driver’s side vanity mirror light began to burn.

Two Philadelphia doctors say the U.S. Food and Drug Administration (FDA) is not doing enough to protect women against cancer that can spread during a morcellation hysterectomy, CBS News reported.

Dr. Amy Reed was diagnosed with cancer in 2013 after undergoing a minimally invasive hysterectomy with a laparoscopic power morcellator- a bladed tool that chops the uterus into tiny pieces to be removed through a small laparoscopic incision. However, according to the FDA ,one in 350 women has undetected sarcoma that can spread throughout the body during the procedure and worsen the cancer and the patient’s prognosis.

Reed and her husband, Dr. Hooman Noorchashm, have been fighting to raise awareness about the risks of morcellator hysterectomy and cancer since her diagnosis. Continue Reading

Japanese manufacturer Takata Corporation recently admitted that its airbags are defective, NBC 10 News reported.

More than 34 million vehicles fitted with Takata airbags have been recalled because the defective canisters can rupture upon impact and spew shrapnel into the vehicle. The defective airbags have resulted in at least six deaths worldwide and hundreds of injuries.

Continue Reading

Contact Information